Polymyalgia Rheumatica
📧 Sign up to get email alerts when something new happens for Polymyalgia Rheumatica.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) [Phase 3]
An open-label, long-term safety study of secukinumab in polymyalgia rheumatica is being conducted in Phase 3. The trial is currently active …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
This clinical trial update describes a qualitative study assessing the severity and impact of rheumatic immune-related adverse events, such …
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency [Phase 4]
Phase 4 clinical trial evaluating supplemental hydrocortisone during stress in patients with prednisolone-induced adrenal insufficiency; cur…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica [Phase 4]
A Phase 4 clinical trial is evaluating the efficacy and safety of sarilumab for adults with early polymyalgia rheumatica; recruitment not ye…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Study of the Association Between Sacroiliitis/Axial Spondylarthritis and Giant Cell Arteritis/ Polymyalgia Rheumatica
This clinical trial update describes a study funded by Hôpital NOVO investigating the association between sacroiliitis/axial spondyloarthrit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Experiencing a PMR Relapse [Phase 3]
A Phase 3 clinical trial is testing whether rituximab reduces glucocorticoid exposure in polymyalgia rheumatica patients experiencing relaps…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment [Phase 4]
Phase 4 clinical trial evaluating hydrocortisone versus placebo in patients with symptoms of adrenal insufficiency after stopping glucocorti…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Giant Cell Arteritis - Ways to Precision Medicine
A recruiting clinical trial at Würzburg University Hospital explores precision medicine approaches for Giant Cell Arteritis and Polymyalgia …
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Treat-to-target Prednisolon Taper in Patients With Polymyalgia Rheumatica [NA]
This clinical trial is evaluating a treat-to-target prednisolone taper strategy in polymyalgia rheumatica; the study is currently active but…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumatica [Phase 3]
A Phase 3 trial to justify and evaluate whether adding baricitinib to corticosteroids improves outcomes versus corticosteroids alone in poly…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Efficacy and Safety of Ivarmacitinib in the Treatment of Patients With Polymyalgia Rheumatica [NA]
A clinical trial is planned to evaluate the efficacy and safety of Ivarmacitinib for polymyalgia rheumatica, with recruitment not yet starte…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Using Novel Imaging to Rethink Diagnostic and Treatment Strategies for Polymyalgia Rheumatica
This clinical trial update describes a study using novel imaging approaches to improve diagnosis and treatment strategies for Polymyalgia Rh…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Improved Diagnostics and Monitoring of Polymyalgia Rheumatica
This clinical trial update describes an ongoing study aimed at improving diagnostics and monitoring for Polymyalgia Rheumatica, with Giant C…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)
A pilot clinical study (THROPIQ) is evaluating whether thrombomodulin can help rule out giant cell arteritis in patients with polymyalgia rh…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
This clinical trial update describes ongoing research in safety and efficacy assessment for rheumatologic diseases and related conditions, w…
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Justification of the Initial Diagnosis and Evaluation of the Overall Evolution of a Cohort of Recent Polymyalgia Rheumatica (JADORE)
This clinical trial update describes the rationale for the initial diagnosis and the evaluation of disease evolution in a cohort of patients…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica [Phase 3]
This is a Phase 3 clinical trial evaluating induction and tapering therapy with tofacitinib in combination with glucocorticoids for polymyal…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: AYLo - AutoimmunitY and Loss of y
Clinical trial AYLo from the University of Bonn investigates autoimmunity across multiple diseases and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic
A University of Bonn clinical trial is currently recruiting to assess a biomarker in patients with giant cell arteritis and polymyalgia rheu…
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis
This study investigates predictive factors for treatment response in patients with newly diagnosed polymyalgia rheumatica and giant cell art…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
The study aims to characterize clinical and immunogenetic features of Giant Cell Arteritis and Polymyalgia Rheumatica. It is currently recru…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS
This clinical trial update describes a study aiming to predict diverse glucocorticoid toxicity outcomes across inflammatory rheumatic diseas…
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.
Registry study evaluating patient-reported outcomes, dosing patterns, and safety of Vunakizumab in several rheumatic diseases; recruitment h…
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: Diagnostic Performance of 18-FDG PET-CT Scores for the Diagnosis of Polymyalgia Rheumatica
A clinical trial update on using 18-FDG PET-CT score-based diagnostics to identify polymyalgia rheumatica; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2017-08-23Clinical Trial Update: Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica
A completed research protocol study focused on quantifying pain to aid in the diagnosis of polymyalgia rheumatica.